Display options
Cite
Azadvari M, Naser Moghadasi A, Azimi AR, et al. Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis. J Multidiscip Healthc. 2020;13:79-83doi: 10.2147/JMDH.S236275.
Azadvari, M., Naser Moghadasi, A., Azimi, A. R., Sharifiaghdas, F., Emami Razavi, S. Z., Eskandarieh, S., Hosseini, M., Rahimi-Dehgolan, S., & Sahraian, M. A. (2020). Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis. Journal of multidisciplinary healthcare, 1379-83. https://doi.org/10.2147/JMDH.S236275
Azadvari, Mohaddeseh, et al. "Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis." Journal of multidisciplinary healthcare vol. 13 (2020): 79-83. doi: https://doi.org/10.2147/JMDH.S236275
Azadvari M, Naser Moghadasi A, Azimi AR, Sharifiaghdas F, Emami Razavi SZ, Eskandarieh S, Hosseini M, Rahimi-Dehgolan S, Sahraian MA. Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis. J Multidiscip Healthc. 2020 Jan 17;13:79-83. doi: 10.2147/JMDH.S236275. eCollection 2020. PMID: 32021237; PMCID: PMC6974412.
Copy Download .nbib Format: NLM
Share it on

J Multidiscip Healthc. 2020 Jan 17;13:79-83. doi: 10.2147/JMDH.S236275. eCollection 2020.

Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis.

Journal of multidisciplinary healthcare

Mohaddeseh Azadvari, Abdorreza Naser Moghadasi, Amir Reza Azimi, Farzaneh Sharifiaghdas, Seyede Zahra Emami Razavi, Sharareh Eskandarieh, Maryam Hosseini, Shahram Rahimi-Dehgolan, Mohammad Ali Sahraian

Affiliations

  1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, I. R. of Iran.
  2. Urology Department, Shahid Labbafinejad Hospital, Urology Nephrology Research Center (UNRC), Shahid Beheshti University of Medical Science(SBMU), Tehran, I. R. of Iran.

PMID: 32021237 PMCID: PMC6974412 DOI: 10.2147/JMDH.S236275

Abstract

PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20-45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of ABSST questionnaire.

METHODS: The standard validation process for preparing the Persian version of ABSST was performed by means of an expert committee. After a pilot study and confirming the harmonized translated form, we tested the final version of questionnaire on 40 patients with a definite diagnosis of MS symptoms, once at the baseline and another after two weeks in order to prevent recall-induced agreement. Test-retest reliability was calculated as Spearman's correlation coefficient. Also, content validity indices (CVIs), as well as internal consistency were analyzed in STATA.

RESULTS: Forty participants with a mean age of 38.8 years were included in this study. Only 20% of them were male. The Persian version achieved a good internal consistency with a Cronbach-α value of 0.91, relatively similar to the original version. The coefficients for measuring the correlation between each item score with the total score of our questionnaire were between 0.58-0.89. This value confirmed an appropriate validity for the Persian version of ABSST. Regarding test-retest reliability assessment, total Spearman`s coefficient was 0.85; with 0.84 for the severity of symptoms and 0.87 for the impact of urologic disorders on patients` social life.

CONCLUSION: The current findings proved that this accurate questionnaire could be used to investigate urinary symptoms among Persian-speaking MS patients.

© 2020 Azadvari et al.

Keywords: multiple sclerosis; questionnaires; reliability; reliability studies; urinary symptoms

Conflict of interest statement

The authors of this article declare that they have no conflict of interests.

References

  1. Clin Ter. 2004 May;155(5):183-6 - PubMed
  2. J Clin Neurosci. 2009 Oct;16(10):1321-4 - PubMed
  3. Int J MS Care. 2013 Winter;15(4):182-92 - PubMed
  4. Mult Scler. 2007 Aug;13(7):915-28 - PubMed
  5. Neurourol Urodyn. 2017 Apr;36(4):1208-1213 - PubMed
  6. Int Urogynecol J. 2014 Dec;25(12):1655-63 - PubMed
  7. Lancet. 2002 Apr 6;359(9313):1221-31 - PubMed
  8. J Neurol Sci. 2015 May 15;352(1-2):37-40 - PubMed
  9. N Engl J Med. 2000 Sep 28;343(13):938-52 - PubMed
  10. Iran J Public Health. 2017 May;46(5):699-704 - PubMed
  11. Mult Scler. 2004 Aug;10(4):455-61 - PubMed
  12. Sex Disabil. 2013 Jun;31(2):141-153 - PubMed

Publication Types